Managing interactions between cognitive enhancers and other psychotropics
Siu W Tang1, Wayne H Tang, Brian E Leonard
1aDepartment of Psychiatry, School of Medicine, University of California, Irvine, California, USA bDepartment of Pharmacology, National University of Ireland, Galway, Ireland cInstitute of Brain Medicine, Hong Kong, China.
Cognitive enhancers are increasingly used in psychiatry, but clinicians need to understand potential drug-drug interactions with psychotropic medications. This review explores these interactions and their impact on patient diagnosis and treatment.
Area of Science:
- Psychiatry
- Pharmacology
- Neuroscience
Background:
- Polypharmacy is prevalent in psychiatric treatment.
- The use of cognitive enhancers in psychiatric patients is rising.
- Clinicians often lack familiarity with novel psychoactive compounds.
Purpose of the Study:
- To review potential drug-drug interactions between cognitive enhancers and psychotropic drugs.
- To examine the confounding effects of these interactions on diagnosis and clinical management.
Main Methods:
- Literature review of existing studies on cognitive enhancers and psychotropic medications.
- Analysis of reported drug-drug interactions.
- Discussion of diagnostic and management challenges.
Main Results:
- Cognitive enhancers may interact with various psychotropic medications.
- These interactions can alter drug efficacy and safety profiles.
- Potential for misdiagnosis or treatment complications exists.
Conclusions:
- Awareness of potential interactions is crucial for safe and effective psychiatric care.
- Further research is needed to elucidate specific interaction mechanisms.
- Guidelines for managing combined use are recommended.
Related Concept Videos
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
Drug Therapy
Antianxiety Medications
Pharmacokinetics: Drug–Drug Interactions
Antidepressant Drugs: MAOIs and Other Agents
Combined Effects of Drugs: Antagonism
The most common type is receptor antagonism, where one drug acts as an antagonist to block the effects of another drug by...
Drugs Affecting Neurotransmitter Release or Uptake


